Page results
-
The clinic at UCH is the world’s first to provide a multi-disciplinary service for adolescents and adults born with diverse sex development.
-
UCLH is considered a centre of excellence in the management of patients with lymphoma.
-
Our mission is to provide state-of-the-art, high-quality, evidence-based and patient-centred treatment for the management of all grades of endometriosis.
-
Patient information for patients undergoing the removal of bot/tumbu flies and jigger fleas.
-
The reproductive medicine unit offers a comprehensive range of investigations and treatments for couples presenting with fertility problems, recurrent miscarriage and reproductive endocrinology.
-
At UCLH, we encourage self-referral to our antenatal service, but you also have the choice to go via your GP who will make the referral for you.
-
I would like to make a payment to UCLH, I have a query about reclaiming expenses for treatment or transport at University College Hospital or I have a query about expenses for treatment or transport at Queen Square (NHNN/RLHIM)
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided cervical (neck) and lumbar (lower back) nerve root injections to patients referred by the Camden community MSK services.
-
This information will help you understand your forthcoming treatment and contains answers to many frequently asked questions.
-
This page is about histiocytic disorders treated at the UCLH haematology department.
File results
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data